Air India has taken a major step to strengthen flight safety by introducing mandatory substance and medication screening for all pilots across the airline group. The new policy goes beyond the existing regulatory testing framework and is aimed at ensuring that pilots operating commercial flights are fit to fly and are not using substances prohibited under aviation regulations.
The decision comes after a serious incident involving an Air India flight operating from Phuket to Delhi. The incident has triggered renewed scrutiny of pilot safety checks and prompted the airline to expand its internal testing procedures.
Mandatory Screening for All Air India Group Pilots
Under the new initiative, pilots across the Air India Group will undergo screening for prohibited substances and medications. The testing will not be restricted to a single location or a particular stage of a pilot's duty cycle.
According to an internal company communication reported on August 13, the screening will be carried out during training sessions, after flights and at designated locations associated with pilots' bases.
The programme will cover pilots working for both Air India and its budget subsidiary, Air India Express. The expanded testing is intended to create an additional layer of safety beyond the minimum regulatory requirements.
Testing to Take Place at Multiple Locations
The airline's new screening programme will operate across several locations. These include the Air India training academy in Gurugram, flight briefing centres and locations connected with pilots' home bases.
Testing during training means that pilots can be screened while attending scheduled training programmes. Additional post-flight screening will provide another opportunity to identify prohibited substances and medications that could potentially affect flight operations.
The move is significant because it makes substance testing a broader part of the airline's internal safety-management system rather than relying only on random regulatory checks.
Decision Follows Phuket-Delhi Flight Incident
The new policy follows a serious incident involving an Air India Airbus A320neo operating from Phuket to Delhi on August 4.
During the flight, the aircraft experienced a sudden loss of altitude of approximately 300 feet while cruising. The incident was subsequently treated as a serious aviation occurrence and became the subject of an investigation.
Following the incident, testing of the flight crew became an important part of the investigation into what happened.
Captain Tested Positive for Marijuana
A major development emerged when the pilot-in-command reportedly returned a positive result for marijuana in a confirmatory laboratory test.
The initial screening had already prompted further testing. According to reports, the subsequent confirmatory test also detected marijuana.
The result has increased attention on the importance of ensuring that flight crew members are not affected by psychoactive substances while operating aircraft.
It is important to note that a positive test result and the circumstances surrounding it must be considered within the applicable aviation and employment investigation process. The result itself does not automatically establish that substance use caused the aircraft incident.
DGCA Rules Already Require Testing
India's aviation regulator, the Directorate General of Civil Aviation (DGCA), already has regulations concerning testing of aviation personnel for psychoactive substances.
Reuters reported that the existing regulatory framework requires random testing of at least 10% of flight crew annually for psychoactive substances.
Air India's new programme goes beyond that minimum requirement by introducing screening for all pilots in the group at multiple stages and locations.
This distinction is important because the airline's new policy is an additional internal safety measure rather than a replacement for DGCA regulations.
Government Takes Safety Concerns Seriously
The development comes at a time when India's civil aviation authorities are facing renewed pressure to strengthen operational safety and crew monitoring.
The government has asked Air India to take greater responsibility for operational safety, while the DGCA has also been directed to review and strengthen its procedures relating to drug and medication testing among aviation personnel.
The aim is to make sure that existing safety mechanisms are strong enough to identify potential risks before they affect flight operations.
Why Pilot Substance Screening Matters
Pilots are responsible for making critical decisions during every stage of a flight. Their ability to remain alert, focused and capable of responding to unexpected situations is therefore a fundamental part of aviation safety.
Certain psychoactive substances and medications can potentially affect alertness, coordination, reaction time or judgment. For this reason, aviation regulations place strict restrictions on the use of substances that could compromise a crew member's ability to safely perform their duties.
Regular screening can help airlines identify potential violations and take appropriate action under their safety and employment procedures.
Air India Expands Safety Checks
The latest move represents an expansion of Air India's internal safety checks. Instead of limiting testing to random regulatory sampling, the airline is introducing a wider screening programme covering its pilot workforce.
The testing process is expected to become part of the airline's broader safety-management framework. Training centres, briefing locations and pilot bases will all play a role in implementing the new system.
Such a system can also help create a stronger culture of compliance among flight crews by making it clear that substance testing is an ongoing safety requirement.
Gurugram Academy to Play an Important Role
The Air India Aviation Training Academy in Gurugram is expected to be one of the important locations for the expanded testing programme.
Air India and Airbus previously established an advanced pilot-training facility at the Gurugram academy. The facility was designed to provide training for Airbus A320 and A350 aircraft families and operates with courses approved by the relevant aviation authorities.
The use of the training environment for additional safety screening allows the airline to integrate testing into existing pilot-training activities.
Post-Flight Testing Also Planned
One of the notable aspects of the new policy is the plan to conduct testing after flights.
Post-flight screening can provide an additional safety check following an operating duty. It can also help the airline investigate potential concerns when circumstances surrounding a flight require closer examination.
The airline is therefore creating a system in which pilots may be tested at different points rather than only during routine random checks.
Air India Express Pilots Also Covered
The new programme is not limited to Air India's mainline operations. Pilots working for Air India Express will also be covered by the expanded screening programme.
This is significant because both airlines operate as part of the wider Air India Group, and maintaining consistent safety standards across the group is important for operational oversight.
DGCA May Tighten Testing Framework
The incident has also prompted attention toward India's wider aviation testing framework.
The Ministry of Civil Aviation has asked the DGCA to review its procedures related to drug testing and to examine whether the existing framework needs to become stricter.
Any regulatory changes would potentially affect not only Air India but aviation personnel across India's commercial aviation sector.
Safety Standards and Passenger Confidence
For passengers, confidence in the fitness and professionalism of flight crews is an essential part of airline safety.
Air India's decision to introduce mandatory screening for all pilots is therefore also intended to reassure passengers and other stakeholders that the airline is taking the issue seriously.
By expanding testing beyond the minimum regulatory requirement, the airline is attempting to establish an additional layer of protection against risks associated with prohibited substances and medications.
Investigation Into Phuket-Delhi Incident Continues
The mandatory screening announcement should not be interpreted as a conclusion about the cause of the Phuket-Delhi incident.
The aircraft's sudden altitude loss remains a matter for the appropriate aviation investigation process. A pilot's test result is one piece of information, while investigators must examine the complete sequence of events, aircraft systems, crew actions, operational conditions and other available evidence.
The government has also directed aviation authorities to strengthen oversight following the incident.
What Happens Next?
Air India's expanded testing programme is expected to be implemented across its pilot workforce, with screening conducted at training facilities, briefing centres and designated base locations.
At the regulatory level, the DGCA is also under pressure to review existing drug-testing procedures for aviation personnel.
The combined approach could result in stricter monitoring of pilots and other flight crew members across India's aviation industry.
Conclusion
Air India has announced mandatory substance and medication screening for all pilots across its group, marking a significant expansion of the airline's internal safety measures.
The decision follows the serious Phuket-Delhi flight incident of August 4 and the subsequent confirmation that the pilot-in-command tested positive for marijuana. The new screening will be conducted during training, after flights and at designated locations including the Gurugram academy, briefing centres and pilot bases.
The programme will also cover Air India Express pilots and goes beyond the existing minimum random-testing requirements under DGCA regulations.
Meanwhile, the aviation regulator is reviewing its own testing framework. The broader objective is to strengthen pilot oversight, improve operational safety and maintain passenger confidence in India's rapidly expanding aviation sector.